Recently, a PET study has shown that the abnormal cholinergic function of individuals with LRRK2 mutations, both with or without PD, was due to increased rates of acetylcholinesterase hydrolysis (Liu et al., 2018). This evidence concerns the gene LRRK2 and Parkinson disease.